Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.01
-3.23%
After-hours: Aug 15, 2025, 04:22 PM EDT

Coherus BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
28.51M -237.89M -291.75M -287.1M
Depreciation & Amortization
5.28M 3.79M 3.7M 3.45M
Stock-Based Compensation
27.8M 43.11M 50.74M 51.36M
Other Working Capital
-57.57M 136.83M -40.41M 13.68M
Other Non-Cash Items
-137.92M 52.93M 75.45M 143.05M
Deferred Income Tax
n/a n/a n/a 9.44M
Change in Working Capital
55.89M -36.83M -79.26M 42.36M
Operating Cash Flow
-20.44M -174.88M -241.12M -37.43M
Capital Expenditures
n/a -286K -2.04M -1.29M
Cash Acquisitions
n/a 845K n/a 1.29M
Purchase of Investments
n/a -19.51M -127.38M -182.49M
Sales Maturities Of Investments
14.89M 157.64M n/a 181.36M
Other Investing Acitivies
215.43M 5.95M -37.43M -137.29M
Investing Cash Flow
230.32M 144.64M -166.85M -138.41M
Debt Repayment
-223.41M n/a 49.93M -672K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
34.98M -2.12M -1.96M 54.3M
Financial Cash Flow
-186.97M 69.6M 54.33M 51.88M
Net Cash Flow
22.91M 39.36M -353.65M -123.96M
Free Cash Flow
-20.44M -175.17M -243.16M -38.72M